|
Volumn 48, Issue 1235, 2006, Pages 41-42
|
Transdermal selegiline (Emsam)
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
BUSPIRONE;
CARBAMAZEPINE;
CITALOPRAM;
CYCLOBENZAPRINE;
DESIPRAMINE;
DEXTROPROPOXYPHENE;
DULOXETINE;
ESCITALOPRAM;
FLUOXETINE;
FLUVOXAMINE;
FLUVOXAMINE MALEATE;
IMIPRAMINE;
ISOCARBOXAZID;
LINEZOLID;
METHADONE;
MIRTAZAPINE;
MONOAMINE OXIDASE A INHIBITOR;
MONOAMINE OXIDASE B INHIBITOR;
NORTRIPTYLINE;
OXCARBAZEPINE;
PAMATE;
PAROXETINE;
PETHIDINE;
PHENELZINE;
PHENYLEPHRINE;
PLACEBO;
PSEUDOEPHEDRINE;
SELEGILINE;
SERTRALINE;
TRAMADOL;
TRANYLCYPROMINE;
UNINDEXED DRUG;
VENLAFAXINE;
ANTIPARKINSON AGENT;
MONOAMINE OXIDASE INHIBITOR;
APPLICATION SITE IRRITATION;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG MECHANISM;
HUMAN;
HYPERTENSIVE CRISIS;
INSOMNIA;
MAJOR DEPRESSION;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
SEROTONIN RELEASE;
SEXUAL DYSFUNCTION;
SHORT SURVEY;
SIDE EFFECT;
WEIGHT REDUCTION;
ARTICLE;
DOUBLE BLIND PROCEDURE;
DRUG INTERACTION;
INTRADERMAL DRUG ADMINISTRATION;
ADMINISTRATION, CUTANEOUS;
ANTIPARKINSON AGENTS;
CLINICAL TRIALS;
DEPRESSIVE DISORDER, MAJOR;
DOUBLE-BLIND METHOD;
DRUG INTERACTIONS;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
PARKINSON DISEASE;
SELEGILINE;
|
EID: 33745504061
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (6)
|
References (6)
|